Breaking News
January 23, 2019 - New certified reference material for testing residual solvents in cannabis
January 23, 2019 - Gene-edited chickens could prevent future flu pandemic
January 23, 2019 - Cardiovascular disease risk begins even before birth
January 23, 2019 - Younger patients receiving kidney transplant more likely to live longer, shows data
January 23, 2019 - Skin samples hold early signs of prion disease, research suggests
January 23, 2019 - Researchers discover how body initiates repair mechanisms that limits damage to myelin sheath
January 23, 2019 - Fecal transplant from certain donors better than others
January 23, 2019 - Risk for Uninsurance in AMI Patients Reduced With Medicaid Expansion
January 23, 2019 - Readmissions reduction program may be associated with increase in patient-level mortality
January 23, 2019 - Fostering translation and communication in medicine and beyond
January 23, 2019 - To Fight Fatty Liver, Avoid Sugary Foods and Drinks
January 23, 2019 - TPU scientists develop new implants that double the rate of bone lengthening in kids
January 23, 2019 - New sessions at Pittcon 2019
January 23, 2019 - Insilico to present latest findings in AI for Drug Discovery at 3rd Annual SABPA FTD Forum
January 23, 2019 - Opioid overdose patients can be safely discharged an hour after administration of naloxone
January 23, 2019 - Scientists find bacterial extracellular vesicles in human blood
January 23, 2019 - Researchers gain new insights into development of necrotizing enterocolitis in preemies
January 23, 2019 - Medical expert advises people with epilepsy not to stockpile medicines
January 23, 2019 - Study outlines research priorities for improving pediatric patient care and safety
January 23, 2019 - Bedfont to exhibit NObreath FeNO monitor at Arab Health 2019
January 23, 2019 - Nicotinamide riboside supplementation confers significant physiological benefits to mothers and offspring
January 23, 2019 - Increasing temperatures may help preserve crop nutrition
January 23, 2019 - Many Oncologists in the Dark About LGBTQ Health Needs
January 23, 2019 - Epigenetic change causes fruit fly babies to inherit diet-induced heart disease
January 23, 2019 - Erasing memories could reduce relapse rates among drug addicts
January 23, 2019 - African Americans who smoke cigarettes are more likely to develop peripheral artery disease
January 23, 2019 - Unique data combination helps FinnGen researchers to fund links between genetic factors and health
January 23, 2019 - Parents’ mental health problems associated with reactive attachment disorder in children
January 23, 2019 - Graphene Flagship project studies impact of graphene and related materials on our health
January 23, 2019 - The connection between the Pope and contraceptive pills
January 23, 2019 - Prior dengue infection could protect children from symptomatic Zika
January 23, 2019 - Previous dengue virus infection associated with protection from symptomatic Zika
January 23, 2019 - VISTA checkpoint implicated in pancreatic cancer immunotherapy resistance
January 23, 2019 - The Tiny Camera That Could Revolutionize Cardiovascular Surgery
January 23, 2019 - Peptide isolated from soil fungi has antitumor and antibacterial properties
January 23, 2019 - TGen identifies polio-like virus as potential cause of Acute Flaccid Myelitis outbreak
January 23, 2019 - Migrants and refugees do not bring disease and are at greater health risk themselves says WHO
January 23, 2019 - Examing the effects of menopause in workplace
January 23, 2019 - Enemy number 1 – Air pollution and climate change top of WHO agenda
January 23, 2019 - Two Positive Phase III studies of Tafenoquine for the Radical Cure of Plasmodium vivax Malaria Published in The New England Journal of Medicine
January 23, 2019 - World Trade Center responders at increased risk for head and neck cancers
January 23, 2019 - Low-sugar diet leads to significant improvement in nonalcoholic fatty liver disease in boys
January 23, 2019 - Chaos in bodily regulation can optimize our immune system, finds study
January 23, 2019 - Short, text-based exercises can increase happiness for adults recovering from substance use disorders
January 23, 2019 - Body size may have greater influence on women’s lifespan than men
January 23, 2019 - Groundbreaking tool helps visualize neuronal activity with near-infrared light
January 23, 2019 - Prior dengue immunity in children may be protective against symptomatic Zika
January 23, 2019 - Holocaust survivors with PTSD and their offspring exhibit more unhealthy behavior patterns
January 23, 2019 - Scientists discover new genetic mutations causing inherited deaf-blindness
January 23, 2019 - UC team designs new naloxone-dispensing smart device
January 23, 2019 - Torrent Pharmaceuticals Limited Issues Voluntary Nationwide Recall of Losartan Potassium Tablets, USP and Losartan Potassium and Hydrochlorothiazide Tablets, USP
January 23, 2019 - Brain activity shows development of visual sensitivity in autism
January 23, 2019 - Two hour gap between dinner and sleep is overrated says Japanese research
January 23, 2019 - Fear and embarrassment are causing smear test numbers to plummet
January 23, 2019 - Protein-secreting device implanted in epileptic rats reduces seizures, improves cognition
January 23, 2019 - Reintroduction project recovers current wild population of green turtle in Cayman Islands
January 23, 2019 - Cancer survivors face greater financial burden related to medical bills
January 23, 2019 - PSA screening reduces prostate cancer deaths by 30%
January 23, 2019 - LSTM receives grant to help improve health of people living in informal settlements
January 23, 2019 - Hemochromatosis Mutation Linked to Other Morbidity
January 23, 2019 - Why early diagnosis of autism should lead to early intervention
January 23, 2019 - Aspirin May Lower Stroke Risk in Women with History of Preeclampsia
January 23, 2019 - Exposure to certain chemicals may be linked to decrease in blood pressure during pregnancy
January 23, 2019 - Bowel cancer on the rise among younger Australians
January 23, 2019 - Scientists have reversed memory loss in a mouse model of Alzheimer’s
January 23, 2019 - Defective molecular master switch could lead to age-related macular degeneration
January 23, 2019 - Researchers identify how concussions may contribute to seizures
January 23, 2019 - Short interval between last meal of the day and bedtime may not affect blood glucose levels
January 23, 2019 - Still Too Many Highway Deaths Tied to Speeding
January 23, 2019 - Prenatal valproate exposure linked to increased ADHD risk
January 23, 2019 - Compound identified that may help treat heart failure
January 23, 2019 - Undiagnosed Asthma in Urban Adolescents May Be Common
January 23, 2019 - Study describes metabolism of intestinal microbiota in babies for the first time
January 22, 2019 - Study links concussions to development of epilepsy
January 22, 2019 - Specialist-led hospital bereavement service may help restrain legal action after difficult deaths
January 22, 2019 - Genetic study reveals possible new routes to treating osteoarthritis
January 22, 2019 - Blood test may detect early signs of lung-transplant rejection
January 22, 2019 - Blood marker could aid in early prediction of Alzheimer’s progression
January 22, 2019 - Orthodontic treatment does not guarantee future dental health
January 22, 2019 - Rutgers researchers discover cause of bone loss in people with joint replacements
Newer Epilepsy Drugs Haven’t Boosted Seizure Control

Newer Epilepsy Drugs Haven’t Boosted Seizure Control

image_pdfDownload PDFimage_print

Action Points

  • Despite the arrival of newer anti-epileptic drugs (AEDs), seizure control hasn’t improved in the last several decades.
  • The study finding suggests that the modern AEDs are seizure-suppressing and not disease-modifying, and do not alter the underlying cause for the seizures.

Despite the arrival of newer anti-epileptic drugs (AEDs), seizure control hasn’t improved in the last several decades, researchers found.

In a large longitudinal cohort study in Scotland, the 1-year seizure-free rate was unchanged over the study period of 1982 to 2012, hovering in the low 60% range, reported Patrick Kwan, MD, PhD, of Royal Melbourne Hospital in Australia, and colleagues.

That means more than a third of epilepsy patients still won’t have adequate seizure control: “Despite the availability of many new AEDs with differing mechanisms of action, overall outcomes in newly diagnosed epilepsy have not improved,” they wrote online in JAMA Neurology.

In 2000, this same research group published outcomes for patients treated from 1982 to 1998, showing that more than a third of epilepsy patients remained uncontrolled. They also found several predictors of poor treatment response, including unknown disease etiology, a high number of seizures before starting therapy, longer duration of epilepsy before the first treatment, history of recreational drug use, family history of epilepsy, history of psychiatric disease, and history of febrile seizures — all of which were again confirmed to predict poor response in this extended version of the study, they said.

More than a dozen new AEDs with different mechanisms of action have come on the market since the earlier study was published, and while some have touted improved safety, all have been reported to have similar efficacy to established AEDs.

For the latest study, Kwan’s group looked at data on 1,795 patients newly treated for epilepsy at Western Infirmary in Glasgow, Scotland, from July 1, 1982 to Oct. 31, 2012. All were followed for a minimum of 2 years (the median follow-up was 11 years) and their median age was 33.

At the end of the study, about 64% had been seizure-free for at least a year, and the proportion of patients who were seizure-free at last follow-up was similar across the three time period subgroups, ranging from 61% to 64%, they reported.

Among those achieving 1-year seizure freedom, 87% were taking monotherapy and 90% achieved seizure control with the first or second AED regimens.

Overall, about half of patients remained seizure-free for at least a year with the initial AED, but if this drug failed, the second and third regimens provided only an additional 12% and 4% likelihood of seizure freedom, respectively. Only 2% of patients achieved optimal seizure control with subsequent AEDs, they reported.

Those with epilepsy that wasn’t controlled with the first AED had a greater likelihood of not responding to treatment for each subsequent medication (OR 1.73, 95% CI 1.56 to 1.91, P<0.001) -- lending support to the definition of drug-resistant epilepsy as "failure of two appropriately selected and tolerated AED regimens," they wrote.

Throughout the trial, there was a marked increase in the use of newer AEDs: the first decade was dominated by carbamazepine, valproate, and phenytoin as initial therapy, while the latter decade was dominated by valproate, levetiracetam, and lamotrigine as initial monotherapy.

“While some modern AEDs have novel anti-seizure mechanisms, their increasing use did not seem to have improved overall long-term seizure control,” the authors wrote. “This may be attributed to deficiencies in the preclinical and clinical strategies of AED development,” such as enrollees being required to have established epilepsy and a high frequency of seizures.

“This finding also suggests that the modern AEDs still lack the capacity to rectify the underlying neuropathological processes and reverse epileptogenesis,” they continued. “Our results provide further evidence that current AEDs are seizure-suppressing and not disease-modifying. Future research should focus on novel treatments that can modify the development or progression of epilepsy, ideally guided by biomarkers.”

In an accompanying editorial, Allen Hauser, MD, of Columbia University in New York City, called the findings “sobering and somewhat disconcerting.”

“The results of this study suggest that the advent of new pharmacological therapies has had little impact on the proportion of newly diagnosed people rendered seizure-free” — a finding that “is not new and should not be surprising.”

Even with the best management, Hauser wrote, “only about two-thirds of people with newly diagnosed epilepsy will be successfully treated … Resources need to be dedicated to developing anti-epilepsy therapies that interfere with or reverse the underlying disease process, rather than merely identifying agents that suppress seizures.”

Kwan and co-authors disclosed relevant relationships with Eisai, UCB Pharma, GlaxoSmithKline, Lundbeck, Bial, GW Pharmaceuticals, Takeda, Sanofi, Abbott, AbbVie, AstraZeneca, Amgen, Johnson & Johnson, and Pfizer.

Hauser disclosed no relevant relationships with industry.

  • Reviewed by
    Robert Jasmer, MD Associate Clinical Professor of Medicine, University of California, San Francisco and Dorothy Caputo, MA, BSN, RN, Nurse Planner

2017-12-27T09:30:00-0500

Tagged with:

About author

Related Articles